Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES Share Price    (DIVI)

Here is the latest stock price and chart of DIVIS LABORATORIES. For more details, see the DIVIS LABORATORIES company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.

Check Out: Why Millions of Dollars are Getting Pumped into this Sector?

REFRESH
Live BSE Quotes Dec 2, 2021 (Close)
Price (Rs)4,778.00 Open (Rs) 4,760.00 High (Rs) 4,825.40 Low (Rs) 4,755.00
% Change0.50 Volume 9,021 Value (Rs) 43,102,338 52-Week H/L 5,425.00 / 3,154.50
Live NSE Quotes Dec 2, 2021 (Close)
Price (Rs)4,777.30 Open (Rs) 4,776.00 High (Rs) 4,824.90 Low (Rs) 4,754.10
% Change0.53 Volume 289,153 Value (Rs) 1,384,738,021 52-Week H/L 5,425.10 / 3,153.30
Change
1 Day
0.50%
1 Month
-8.19%
3 Months
-7.46%
1 Year
31.27%
5 Years (CAGR)*
33.30%
10 Years (CAGR)*
28.75%

* Compound Annual Growth Rate

Valuation
EPS (Rs)* 80.47 P/E Ratio (x) 59.38 Market Cap (Rs m) 1,268,408.97 P/BV (x) 13.65 Dividend Yield (%) 0.42
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
 
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

DIVIS LABORATORIES Share Price Today:

DIVIS LABORATORIES last traded price was up 0.5% to Rs 4,778.0 on the BSE. On the NSE, DIVIS LABORATORIES last traded price was up 0.5% to Rs 4,777.3. The total volume of shares traded was 0.3 m.

Overall, the broader S&P BSE HEALTHCARE Index was up by 0.9%. And the benchmark S&P BSE SENSEX was at 58,461.3 (up 1.4%).

Over the last 30 days, the DIVIS LABORATORIES share price is down 8.7%. And over the last one year, DIVIS LABORATORIES share price is up 32.0%.

The current market capitalisation of DIVIS LABORATORIES stands at Rs 1,268,408.97 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of September 2021, company promoters held 51.95% stake in DIVIS LABORATORIES, with no shares having been pledged. To know more, check out the latest shareholding pattern of DIVIS LABORATORIES.


What else is happening in the markets today? Dig in...


Today's Market

Sensex Zooms 777 Points, Nifty Ends Above 17,400; Power & IT Stocks Rally(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views On News

DIVIS LABORATORIES 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of DIVIS LABORATORIES for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

DIVIS LABORATORIES Announces Quarterly Results (1QFY22); Net Profit Up 13.2% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, DIVIS LABORATORIES has posted a net profit of Rs 6 bn (up 13.2% YoY). Sales on the other hand came in at Rs 20 bn (up 13.3% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (4QFY21); Net Profit Up 29.3% (Quarterly Result Update)

Jun 28, 2021 | Updated on Jun 28, 2021

For the quarter ended March 2021, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 29.3% YoY). Sales on the other hand came in at Rs 18 bn (up 28.7% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better? (Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake (Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks (Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

How to Find Your Next 10-Bagger in this Market (Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

MobiKwik IPO Opens for Subscription Soon. Key Things to Know Before Subscribing. (Views On News)

Nov 20, 2021

The Rs 19 bn issue is set to hit the market soon.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - PANACEA BIOTECH COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS